Abstract:Background Major depressive disorder (MDD) is a prevalent mental health condition characterized by recurrent episodes in a substantial proportion of patients. The number of previous episodes is one of the most crucial predictors of depression recurrence. However, the underlying neural mechanisms remain unclear. To date, there have been limited neuroimaging studies investigating morphological changes of the brainstem in patients with first-episode MDD (FMDD) and recurrent MDD (RMDD). This study aimed to examine volumetric changes of individual brainstem regions in relation to the number of previous episodes and disease duration. Method A total of 111 individuals including 36 FMDD, 25 RMDD, and 50 healthy controls (HCs) underwent T1-weighted structural magnetic resonance imaging scans. A Bayesian segmentation algorithm was used to analyze the volume of each brainstem region, including the medulla oblongata, pons, midbrain, and superior cerebellar peduncle (SCP), as well as the whole brainstem volume. Analyses of variance (ANOVA) were performed to obtain brain regions with significant differences among three groups and then post hoc tests were calculated for inter-group comparisons. Partial correlation analyses were further conducted to identify associations between regional volumes and clinical features. Results The ANOVA revealed significant brainstem volumetric differences among three groups in the pons, midbrain, SCP, and the whole brainstem ( F = 3.996 ~ 5.886, adjusted p = 0.015 ~ 0.028). As compared with HCs, both groups of MDD patients showed decreased volumes in the pons as well as the entire brainstem ( p = 0.002 ~ 0.034), however, only the FMDD group demonstrated a significantly reduced volume in the midbrain ( p = 0.003). Specifically, the RMDD group exhibited significantly decreased SCP volume when comparing to both FMDD ( p = 0.021) group and HCs ( p = 0.008). Correlation analyses revealed that the SCP volumes were negatively associated with the number of depressive episodes ( r =-0.36, p < 0.01) and illness duration ( r =-0.28, p = 0.035) in patients with MDD. Conclusion The present findings provided evidence of decreased brainstem volume involving in the pathophysiology of MDD, particularly, volumetric reduction in the SCP might represent a neurobiological marker for RMDD. Further research is needed to confirm our observations and deepen our understanding of the neural mechanisms underlying depression recurrence.

Alterations in Arginine Vasopressin Neurons in the Suprachiasmatic Nucleus in Depression

Increased Glutamic Acid Decarboxylase Expression in the Hypothalamic Suprachiasmatic Nucleus in Depression

Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain

Decreased Vasopressin Gene Expression in the Biological Clock of Alzheimer Disease Patients with and Without Depression

Aromatase Changes in Depression: A Postmortem and Animal Experimental Study.

Different Oxytocin and Corticotropin-Releasing Hormone System Changes in Bipolar Disorder and Major Depressive Disorder Patients

Effects of Antidepressant on the Expression of Neuropeptide Y in Brain of a Rat Model of Depression Induced by Chronic Stress

Alterations of Brainstem Volume in Patients with First-Episode and Recurrent Major Depressive Disorder

Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.

Glucocorticoids Suppress Vasopressin Gene Expression in Human Suprachiasmatic Nucleus.

Gene Expression Analysis in the Human Hypothalamus in Depression by Laser Microdissection and Real-Time Pcr: the Presence of Multiple Receptor Imbalances

Circadian rhythm of Arg-vasopressin contents in the suprachiasmatic nucleus in relation to corticosterone

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei.

Functional connectivity of suprachiasmatic nucleus in major depressive episodes patients with morn-ing heavy night light rhythm

Aberrant Stress Hormone Receptor Balance in the Human Prefrontal Cortex and Hypothalamic Paraventricular Nucleus of Depressed Patients.

Diurnal Alterations in Circadian Genes and Peptides in Major Depressive Disorder Before and after Escitalopram Treatment.

Arginine vasopressin: Critical regulator of circadian homeostasis

Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus

Diurnal Mood Variation Symptoms in Major Depressive Disorder Associated with Evening Chronotype: Evidence from a Neuroimaging Study.

Aberrant functional connectivity between the suprachiasmatic nucleus and the superior temporal gyrus: Bridging RORA gene polymorphism with diurnal mood variation in major depressive disorder